Financial reports
10-Q
2024 Q2
Quarterly report
7 Feb 24
10-Q
2024 Q1
Quarterly report
8 Nov 23
ARS
2023 FY
Annual report to shareholders
15 Sep 23
10-K
2023 FY
Annual report
30 Aug 23
10-Q
2023 Q3
Quarterly report
3 May 23
10-Q
2023 Q2
Quarterly report
8 Feb 23
10-Q
2023 Q1
Quarterly report
9 Nov 22
10-K
2022 FY
Annual report
24 Aug 22
10-Q
2022 Q3
Quarterly report
4 May 22
10-Q
2022 Q2
Quarterly report
9 Feb 22
Current reports
8-K
Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance
7 Feb 24
8-K
Phibro Animal Health Corporation Declares Quarterly Dividend
6 Feb 24
8-K
Phibro Animal Health Corporation Announces Chief Financial Officer Changes
6 Feb 24
8-K
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance
8 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
7 Nov 23
8-K
Phibro Animal Health Corporation Reiterates Safety of Mecadox® and Intent to Defend its Use for Customers
7 Nov 23
8-K
Phibro Animal Health Corporation Declares Quarterly Dividend
6 Nov 23
8-K
Phibro Animal Health Corporation Announces Chief Financial Officer Changes
5 Sep 23
8-K
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
30 Aug 23
8-K
Phibro Animal Health Corporation Declares Quarterly Dividend
25 Jul 23
Registration and prospectus
S-8
Registration of securities for employees
18 Sep 14
424B4
Prospectus supplement with pricing info
14 Apr 14
S-1MEF
Registration of additional securities for an S-1
11 Apr 14
S-1/A
IPO registration (amended)
10 Apr 14
FWP
Free writing prospectus
10 Apr 14
8-A12B
Registration of securities on exchange
8 Apr 14
S-1/A
IPO registration (amended)
8 Apr 14
S-1/A
IPO registration (amended)
4 Apr 14
S-1/A
IPO registration (amended)
31 Mar 14
S-1
IPO registration
10 Mar 14
Proxies
DEFA14A
Additional proxy soliciting materials
15 Sep 23
DEF 14A
Definitive proxy
15 Sep 23
DEFA14A
Additional proxy soliciting materials
16 Sep 22
DEF 14A
Definitive proxy
16 Sep 22
DEFA14A
Additional proxy soliciting materials
17 Sep 21
DEF 14A
Definitive proxy
17 Sep 21
DEFA14A
Additional proxy soliciting materials
18 Sep 20
DEF 14A
Definitive proxy
18 Sep 20
DEFA14A
Additional proxy soliciting materials
20 Sep 19
DEF 14A
Definitive proxy
20 Sep 19
Other
CT ORDER
Confidential treatment order
19 Nov 18
UPLOAD
Letter from SEC
11 Apr 17
CORRESP
Correspondence with SEC
15 Mar 17
UPLOAD
Letter from SEC
6 Mar 17
CT ORDER
Confidential treatment order
20 Jun 16
CT ORDER
Confidential treatment order
11 Aug 15
EFFECT
Notice of effectiveness
10 Apr 14
CORRESP
Correspondence with SEC
8 Apr 14
CORRESP
Correspondence with SEC
8 Apr 14
UPLOAD
Letter from SEC
7 Apr 14
Ownership
144
Notice of proposed sale of securities
5 Mar 24
SC 13D/A
BFI Co., LLC
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Glenn David
9 Feb 24
3
Glenn David
9 Feb 24
SC 13G
PZENA INVESTMENT MANAGEMENT LLC
8 Feb 24
SC 13G/A
BlackRock Inc.
19 Jan 24
SC 13G
BRANDES INVESTMENT PARTNERS, LP
10 Jan 24
SC 13G
BRANDES INVESTMENT PARTNERS, LP
8 Dec 23
144
Notice of proposed sale of securities
5 Dec 23